Trial Profile
Pharmacokinetic and pharmacodynamic study of imatinib in patients with gastrointestinal stromal tumour
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2016
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Pharmacodynamics; Pharmacokinetics
- 29 Sep 2016 New trial record